SI
TECH icon

Stephens Inc’s Bio-Techne TECH Stock Holding History

Stephens Inc’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$850K Sell
12,036
-386
-3% -$20.8K 0.01% 725
2026
Q1 		$649K Buy
12,422
+3,176
+34% +$191K 0.01% 778
2025
Q4 		$544K Buy
9,246
+824
+10% +$50.1K 0.01% 819
2025
Q3 		$469K Buy
8,422
+273
+3% +$14.6K 0.01% 875
2025
Q2 		$419K Buy
8,149
+367
+5% +$18.4K 0.01% 903
2025
Q1 		$456K Sell
7,782
-1,064
-12% -$72.1K 0.01% 851
2024
Q4 		$637K Buy
8,846
+1,834
+26% +$135K 0.01% 744
2024
Q3 		$560K Buy
7,012
+217
+3% +$16.3K 0.01% 798
2024
Q2 		$487K Buy
6,795
+17
+0.3% +$1.25K 0.01% 810
2024
Q1 		$477K Sell
6,778
-85
-1% -$6.08K 0.01% 829
2023
Q4 		$530K Sell
6,863
-502
-7% -$33.1K 0.01% 728
2023
Q3 		$501K Sell
7,365
-124
-2% -$9.8K 0.01% 724
2023
Q2 		$611K Buy
7,489
+750
+11% +$60.3K 0.01% 677
2023
Q1 		$500K Buy
6,739
+131
+2% +$10.1K 0.01% 715
2022
Q4 		$548K Buy
6,608
+1,844
+39% +$146K 0.01% 664
2022
Q3 		$338K Sell
4,764
-72
-1% -$6.22K 0.01% 852
2022
Q2 		$419K Sell
4,836
-224
-4% -$21K 0.01% 786
2022
Q1 		$548K Buy
5,060
+164
+3% +$16.9K 0.01% 772
2021
Q4 		$633K Buy
4,896
+364
+8% +$44.6K 0.01% 775
2021
Q3 		$549K Buy
4,532
+360
+9% +$43.8K 0.01% 832
2021
Q2 		$470K Buy
4,172
+308
+8% +$32.4K 0.01% 906
2021
Q1 		$369K Sell
3,864
-1,984
-34% -$181K 0.01% 932
2020
Q4 		$464K Buy
5,848
+400
+7% +$29K 0.01% 804
2020
Q3 		$337K Buy
5,448
+2,120
+64% +$138K 0.01% 835
2020
Q2 		$220K Buy
3,328
+4
+0.1% +$240 ﹤0.01% 942
2020
Q1 		$158K Buy
3,324
+52
+2% +$2.6K ﹤0.01% 921
2019
Q4 		$180K Sell
3,272
-4,136
-56% -$217K ﹤0.01% 1017
2019
Q3 		$362K Buy
7,408
+68
+0.9% +$3.41K 0.01% 849
2019
Q2 		$383K Sell
7,340
-604
-8% -$30.4K 0.01% 827
2019
Q1 		$394K Buy
7,944
+144
+2% +$6.48K 0.01% 820
2018
Q4 		$282K Sell
7,800
-1,912
-20% -$79.9K 0.01% 875
2018
Q3 		$496K Buy
9,712
+1,288
+15% +$57K 0.01% 781
2018
Q2 		$312K Buy
8,424
+556
+7% +$21.2K 0.01% 711
2018
Q1 		$297K Buy
7,868
+6,044
+331% +$214K 0.01% 578
2017
Q4 		$59K Buy
1,824
+196
+12% +$6.23K ﹤0.01% 683
2017
Q3 		$49K Buy
+1,628
New +$48.3K ﹤0.01% 698
2014
Q4 		– Sell
-516
Closed -$12K – 845
2014
Q3 		$12K Hold
516
– – ﹤0.01% 798
2014
Q2 		$12K Sell
516
-24
-4% -$530 ﹤0.01% 822
2014
Q1 		$12K Sell
540
-11,048
-95% -$249K ﹤0.01% 781
2013
Q4 		$274K Buy
11,588
+1,700
+17% +$36.8K 0.01% 679
2013
Q3 		$198K Sell
9,888
-60
-0.6% -$1.14K 0.01% 725
2013
Q2 		$172K Buy
+9,948
New +$165K 0.01% 660

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Stephens Inc's TECH Position: Q2 2026 in Review

Stephens Inc reduced its Bio-Techne (TECH) stake by 3.1% in Q2 2026, selling an estimated $20.8K and leaving 12,036 shares worth $850K. The position accounts for 0.01% of the portfolio, ranked #725.

Stephens Inc first reported a position in TECH in Q2 2013 and has held it in 42 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Stephens Inc held 12,036 shares of Bio-Techne worth $850K as of Q2 2026.
  • Stephens Inc sold 386 Bio-Techne shares in Q2 2026, an estimated $20.8K.
  • Bio-Techne made up 0.01% of Stephens Inc's portfolio in Q2 2026, its #725 holding.
  • Stephens Inc first reported a position in Bio-Techne in Q2 2013 and has held it in 42 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.